Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study.

Source:http://linkedlifedata.com/resource/pubmed/id/15875087

Download in:

View as

General Info

PMID
15875087